| ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents A Levine, S Koletzko, D Turner, JC Escher, S Cucchiara, L de Ridder, ... Journal of pediatric gastroenterology and nutrition 58 (6), 795-806, 2014 | 1232 | 2014 |
| Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease FM Ruemmele, G Veres, KL Kolho, A Griffiths, A Levine, JC Escher, ... Journal of Crohn's and Colitis 8 (10), 1179-1207, 2014 | 1189 | 2014 |
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations G Van Assche, A Dignass, W Reinisch, CJ van der Woude, A Sturm, ... Journal of Crohn's and Colitis 4 (1), 63-101, 2010 | 948 | 2010 |
| Coeliac disease M Mäki, P Collin The lancet 349 (9067), 1755-1759, 1997 | 881 | 1997 |
| ESPEN guideline: Clinical nutrition in inflammatory bowel disease A Forbes, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ... Clinical Nutrition 36 (2), 321-347, 2017 | 726 | 2017 |
| European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations R Caprilli, MA Gassull, JC Escher, G Moser, P Munkholm, A Forbes, ... Gut 55 (suppl 1), i36-i58, 2006 | 650 | 2006 |
| Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function DS Shouval, A Biswas, JA Goettel, K McCann, E Conaway, NS Redhu, ... Immunity 40 (5), 706-719, 2014 | 591 | 2014 |
| Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis JF Dekkers, G Berkers, E Kruisselbrink, A Vonk, HR De Jonge, ... Science translational medicine 8 (344), 344ra84-344ra84, 2016 | 562 | 2016 |
| The medical management of paediatric Crohn’s disease: an ECCO-ESPGHAN guideline update PF Van Rheenen, M Aloi, A Assa, J Bronsky, JC Escher, UL Fagerberg, ... Journal of Crohn's and Colitis 15 (2), 171-194, 2021 | 497 | 2021 |
| Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines D Turner, A Levine, JC Escher, AM Griffiths, RK Russell, A Dignass, ... Journal of pediatric gastroenterology and nutrition 55 (3), 340-361, 2012 | 472 | 2012 |
| Inflammatory bowel disease in children and adolescents: recommendations for diagnosis‐the Porto criteria IBD Working Group of the European Society for Paediatric Gastroenterology ... Journal of Pediatric Gastroenterology and Nutrition 41 (1), 1-7, 2005 | 384* | 2005 |
| ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease SC Bischoff, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ... Clinical Nutrition 39 (3), 632-653, 2020 | 341 | 2020 |
| European evidence-based consensus on the management of ulcerative colitis: special situations L Biancone, P Michetti, S Travis, JC Escher, G Moser, A Forbes, ... Journal of Crohn's and Colitis 2 (1), 63-92, 2008 | 320 | 2008 |
| Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis J Hyams, L Damaraju, M Blank, J Johanns, C Guzzo, HS Winter, ... Clinical Gastroenterology and hepatology 10 (4), 391-399. e1, 2012 | 308 | 2012 |
| European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and … A Levine, S Koletzko, D Turner, JC Escher, S Cucchiara, L De Ridder, ... J Pediatr Gastroenterol Nutr 58 (6), 795-806, 2014 | 254 | 2014 |
| Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN D Turner, SPL Travis, AM Griffiths, FM Ruemmele, A Levine, EI Benchimol, ... Official journal of the American College of Gastroenterology| ACG 106 (4 …, 2011 | 251 | 2011 |
| Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease R Baldassano, CP Braegger, JC Escher, K DeWoody, DF Hendricks, ... Official journal of the American College of Gastroenterology| ACG 98 (4 …, 2003 | 226 | 2003 |
| Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti, S Cucchiara, ... Gastroenterology 152 (8), 1901-1914. e3, 2017 | 219 | 2017 |
| Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric … E Miele, R Shamir, M Aloi, A Assa, C Braegger, J Bronsky, L De Ridder, ... Journal of pediatric gastroenterology and nutrition 66 (4), 687-708, 2018 | 212 | 2018 |
| Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry CI De Bie, A Paerregaard, S Kolacek, FM Ruemmele, S Koletzko, ... Inflammatory bowel diseases 19 (2), 378-385, 2013 | 209 | 2013 |
